MEDIGENE AG NA O.N./ DE000A1X3W00 /
| 2024-04-26 1:36:25 PM | Chg. -0.05 | Volume | Bid1:37:27 PM | Ask1:37:27 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.56EUR | -3.11% | 23,605 Turnover: 36,950.56 |
1.56Bid Size: 1,700 | 1.60Ask Size: 1,600 | 39.67 mill.EUR | 0.00% | - |
Assets
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2.5000 | 3.3000 | 4.3000 | 4.3000 | 8.8000 | ||||||
| Intangible Assets | 33.5000 | 33.6000 | 34.1000 | 34 | 33.5000 | ||||||
| Long-Term Investments | 13 | 5.9000 | 5.7000 | 25.6000 | 3.6000 | ||||||
| Fixed Assets | 51.6000 | 47.7000 | 48.6000 | 67.4000 | 51.5000 | ||||||
| Inventories | 6.7000 | 7.9000 | 7.7000 | 7.3000 | 0.0000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 8.8000 | 14.6000 | 27.7000 | 27.4000 | 34.7000 | ||||||
| Current Assets | 59.9000 | 64 | 63.3000 | 62.2000 | 57.7000 | ||||||
| Total Assets | 113.5000 | 111.7000 | 111.9000 | 129.6000 | 109.2000 | ||||||
Liabilities
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.4000 | 1 | .7000 | 1.4000 | 1.4000 | ||||||
| Long-term debt | 11 | 9.7000 | 7.6000 | .8000 | - | ||||||
| Liabilities to Banks | 18.9000 | 16.9000 | 12.4000 | 4.1000 | 3.2000 | ||||||
| Provisions | 2 | 1.6000 | 2.2000 | 3 | 2.4000 | ||||||
| Liabilities | 23.5000 | 33.1000 | 25.8000 | 22.2000 | 27.4000 | ||||||
| Share Capital | 19.6780 | 20.1370 | 22.3010 | 24.5570 | 24.5630 | ||||||
| Total Equity | 90 | 78.6000 | 86.2000 | 107.4000 | 81.8000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 113.5000 | 111.7000 | 111.9000 | 129.6000 | 109.2000 | ||||||
Income Statement
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3.1000 | 4.1000 | 7.7000 | 7.6000 | 10.5000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -10.4000 | -13.2000 | -13.4000 | -17.8000 | -20.2000 | ||||||
| Interest Income | -2.9400 | -1 | -1.4000 | .1000 | -.3000 | ||||||
| Income Before Taxes | -13.4000 | -9.7000 | -12.9000 | -17 | -19.9000 | ||||||
| Income Taxes | -.4000 | -.2000 | .6000 | .0500 | .0400 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -13 | -9.5000 | -13.6000 | -17 | -20 | ||||||
Per Share
Cash Flow
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -10.6000 | -3.8000 | -20.8000 | -10.1000 | -16.4000 | ||||||
| Cash Flow from Investing Activities | -39.4000 | 9.9000 | 15.2000 | -19.5000 | 24.2000 | ||||||
| Cash Flow from Financing | 43.8000 | -.2000 | 18.7000 | 29.3000 | -.5000 | ||||||
| Decrease / Increase in Cash | -6.2000 | 5.9000 | 13.1000 | -.3000 | 7.3000 | ||||||
| Employees | 73 | 88 | 91 | 98 | 123 | ||||||
